Fig. 4
Cumulative incidence of HCC development using TSP2-48W. HCC, hepatocellular carcinoma; TSP2, thrombospondin 2; TSP2-48W, TSP2 levels measured 48 weeks after nucleos(t)ide analog administration.
Fig. 4 | Scientific Reports
Cumulative incidence of HCC development using TSP2-48W. HCC, hepatocellular carcinoma; TSP2, thrombospondin 2; TSP2-48W, TSP2 levels measured 48 weeks after nucleos(t)ide analog administration.
